A popular sweetener could result in bacterial overgrowth and symptom worsening among patients with Crohn disease.
Pan-fibroblast growth factor receptor tyrosine kinase inhibitor demonstrates efficacy in urothelial cancer.
Several genes observed to protect against neuronal toxicity caused by amyotrophic lateral sclerosis.
Study suggests that supportive care may vary between National Cancer Institute-designated cancer centers and non-designated centers.
Induced neural stem cells may hold the key to reducing multiple sclerosis-related central nervous system damage.
Top news of the day from across the health care landscape.
WellDyneRx created an innovative program that controls costs and improves outcomes for patients with diabetes, according to a session presented at APhA2018.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.